Organization typesPublic Company

Products 1 to 10 of 122

Accellerase TRIO by DuPont + Genencor
Biotech components: Enzyme
Business models: B2B
Country of production: USA
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/09/20 09:09 (2 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Fuel and Energy
Production process: Closed Production
Source: SynBio Database
Trading symbol: DWDP (NYSE)
Value chain stage: Input
Biotech components: Plant
Business models: B2C
Country of production: Netherlands
Country of distribution: USA + Netherlands
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/10/01 09:58 (2 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Public Company
Product categories: Food
Production process: Closed Production
Source: NASEM Database
Trading symbol: CRBN (AEX)
Value chain stage: Finished Product
Antibiotic - EV-035 by Emergent Biosolutions, Inc.
Biotech components: Bacteria
Business models: B2C
Country of production: USA
Country of distribution: USA + Switzerland
Intended consumer: Government
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/08/30 11:49 (2 years ago)
Known funding amount: 86,000,000 CHF
Funding types: Shareholder Investment
Industry: Health
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: EVE (SWX)
Value chain stage: Finished Product
AquAdvantage Salmon (#2) by AquaBounty
Biotech components: Animal
Business models: B2C
Country of production: USA
Country of distribution: USA + Canada
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/09/06 10:13 (2 years ago)
Known funding amount: 38,000,000 USD
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Public Company
Product categories: Food
Production process: Open Release
Source: NASEM Database
Trading symbol: AQB (NASDAQ)
Value chain stage: Finished Product
Arctic Apple by Okanagan Specialty Fruits + Intrexon
Biotech components: Plant
Business models: B2C
Country of production: USA
Country of distribution: USA + Canada
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/10/02 15:47 (2 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Public Company
Product categories: Food
Production process: Open Release
Source: NASEM Database
Trading symbol: XON (NYSE)
Value chain stage: Finished Product
Artemisinic Acid by Amyris
Biotech components: Probiotic
Business models: B2B
Country of production: USA
Country of distribution: USA + Africa + France
Intended consumer: Commercial + Government
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/08/30 11:49 (2 years ago)
Known funding amount: 471,900,000 USD
Funding types: Shareholder Investment
Industry: Health
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: AMRS (NASDAQ)
Value chain stage: Input
AZT-01 by Azitra
Biotech components: Bacteria
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:14 (1 year ago)
Date last modified: 2019/09/12 15:14 (1 year ago)
Known funding amount: N/A
Funding types: Government + Private Funding
Industry: Health + Medical
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Personal Care (Topical)
Production process: N/A
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product
AZT-02 by Azitra
Biotech components: Bacteria
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:14 (1 year ago)
Date last modified: 2019/09/12 15:14 (1 year ago)
Known funding amount: N/A
Funding types: Government + Private Funding
Industry: Health + Medical
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Personal Care (Topical)
Production process: N/A
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product
AZT-04 by Azitra
Biotech components: Bacteria
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:15 (1 year ago)
Date last modified: 2019/09/12 15:15 (1 year ago)
Known funding amount: N/A
Funding types: Government + Private Funding
Industry: Health
Market status: Under Development
Organization type(s): Public Company
Product categories: Personal Care (Topical)
Production process: N/A
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product
AZT-05 by Azitra
Biotech components: Bacteria
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:14 (1 year ago)
Date last modified: 2019/09/12 15:14 (1 year ago)
Known funding amount: N/A
Funding types: Government + Private Funding
Industry: Health + Medical
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Personal Care (Topical)
Production process: N/A
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product